Insilico Biotechnology is a market-leading company providing predictive solutions for the Bioeconomy. An interdisciplinary team of experts offers mechanistic models, customized software, and a high performance computing platform for the simulation of living cells.
Based on our expertise in reconstructing genome-based network models, we use data from our customer‘s bioprocess to generate a model that represents the customer‘s host organism. Using this model we simulate how cells behave in a bioprocess to identify the best conditions. Our simulations significantly reduce the experimental effort required during upstream bioprocess development:
Automated time-resolved process analysis in manufacturing
Media optimization in process development
Clone analysis and clone selection in cell line development
Metabolic network simulations for metabolic engineering
Customers benefit from our technology either as a service or by licensing our software solutions. To promote knowledge transfer, we provide expert training, consulting, and software customization. For world-leading pharma and biotech companies Insilico‘s technology lowers time, risk and costs of process development.
Insilico and Janssen take another step towards predictive biomanufacturing: Digital Twins allow for accelerated timelines in cell line development for biologics production
Insilico Biotechnology AG and the Janssen Pharmaceutical Companies of Johnson & Johnson announced an agreement to apply Insilico's predictive Digital Twins for the early…
Insilico Biotechnology AG and the Laboratory of Systems Theory and Automatic Control at the Institute for Automation Engineering (IFAT) of the Otto von Guericke University…